Cargando…
Antithrombotic agents in patients with COVID-19
Autores principales: | Khan, Faizan, Tritschler, Tobias, Zarychanski, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188790/ https://www.ncbi.nlm.nih.gov/pubmed/35609908 http://dx.doi.org/10.1503/cmaj.220189 |
Ejemplares similares
-
Antithrombotiques chez les patients atteints de COVID-19
por: Khan, Faizan, et al.
Publicado: (2022) -
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022) -
The Impact of COVID-19 Research on the Development of Scalable Frameworks for Efficient Clinical Trials in Cardiovascular Medicine
por: Godoy, Lucas C., et al.
Publicado: (2023) -
Antithrombotic Agents and Cancer
por: Bruno, Annalisa, et al.
Publicado: (2018) -
The Employment of Blisters in Acute Diseases of the Brain
por: Tritschler,
Publicado: (1846)